Delivery Order SPE2DB20D1004-SPE2DB24FNCTP

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,145.16, is a firm fixed-price delivery order for 4566839625 ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,036.23 Firm Fixed Price delivery order is for the provision of 4567566056 ! ONDANSETRON ODT 4 MG TABLET 30S, a generic pharmaceutical product, with a completion date of March 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,326.72, is a delivery order for the supply of 4566661254 - ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,562.80 firm-fixed-price delivery order is for 4567222878 - ONDANSETRON ODT 4 MG TABLET 30S, with a period of performance through February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,686.98, is a delivery order for the supply of 4564882367 ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,566.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4564858890 - ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,661.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for 4568143819 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,915.26 Firm Fixed Price Delivery Order is for the supply of 4567089257 - ONDANSETRON ODT 8 MG TABLET 30S, with a completion date of January 30, 2025. The contract is not associated with any set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,593.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order to supply the government with ONDANSETRON HCL 4 MG TABLET 30S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,364.35, is a Firm Fixed Price Delivery Order for the supply of 4567201817 ! ONDANSETRON ODT 8 MG TABLET 30S. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCTP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.64, is a delivery order for the supply of 4565924661 - ONDANSETRON HCL 4 MG TABLET UD 100S. There is no set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 12:40 PM